Sergey Yurasov - Net Worth and Insider Trading

Sergey Yurasov Net Worth

The estimated net worth of Sergey Yurasov is at least $460,723 dollars as of 2024-05-26. Sergey Yurasov is the Sr. VP, Clinic. Devel. & CMO of Immune Design Corp and owns about 78,756 shares of Immune Design Corp (IMDZ) stock worth over $460,723. Details can be seen in Sergey Yurasov's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sergey Yurasov has not made any transactions after 2019-01-07 and currently still holds the listed stock(s).

Transaction Summary of Sergey Yurasov

To

Sergey Yurasov Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sergey Yurasov owns 2 companies in total, including Nuvation Bio Inc (NUVB) , and Black Diamond Therapeutics Inc (BDTX) .

Click here to see the complete history of Sergey Yurasov’s form 4 insider trades.

Insider Ownership Summary of Sergey Yurasov

Ticker Comapny Transaction Date Type of Owner
NUVB Nuvation Bio Inc 2021-02-10 Chief Medical Officer
BDTX Black Diamond Therapeutics Inc 2023-02-13 CHIEF MEDICAL OFFICER

Sergey Yurasov Latest Holdings Summary

Sergey Yurasov currently owns a total of 1 stock. Sergey Yurasov owns 78,756 shares of Immune Design Corp (IMDZ) as of January 7, 2019, with a value of $460,723.

Latest Holdings of Sergey Yurasov

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMDZ Immune Design Corp 2019-01-07 78,756 5.85 460,723

Holding Weightings of Sergey Yurasov


Sergey Yurasov Form 4 Trading Tracker

According to the SEC Form 4 filings, Sergey Yurasov has made a total of 0 transactions in Immune Design Corp (IMDZ) over the past 5 years. The most-recent trade in Immune Design Corp is the sale of 3,522 shares on January 7, 2019, which brought Sergey Yurasov around $5,530.

Insider Trading History of Sergey Yurasov

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sergey Yurasov Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sergey Yurasov Ownership Network

Ownership Network List of Sergey Yurasov

No Data

Ownership Network Relation of Sergey Yurasov


Sergey Yurasov Owned Company Details

What does Nuvation Bio Inc do?

Who are the key executives at Nuvation Bio Inc?

Sergey Yurasov is the Chief Medical Officer of Nuvation Bio Inc. Other key executives at Nuvation Bio Inc include Chief Medical Officer Dongfang Liu , 10 percent owner Omega Fund V Gp, L.p. , and 10 percent owner Omega Fund Iv Gp, L.p. .

Nuvation Bio Inc (NUVB) Insider Trades Summary

Over the past 18 months, Sergey Yurasov made no insider transaction in Nuvation Bio Inc (NUVB). Other recent insider transactions involving Nuvation Bio Inc (NUVB) include a net purchase of 10,626,200 shares made by Oleg Nodelman , and a net purchase of 250,000 shares made by Kathryn E Falberg .

In summary, during the past 3 months, insiders sold 0 shares of Nuvation Bio Inc (NUVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nuvation Bio Inc (NUVB) were sold and 10,876,200 shares were bought by its insiders, resulting in a net purchase of 10,876,200 shares.

Nuvation Bio Inc (NUVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nuvation Bio Inc Insider Transactions

No Available Data

Sergey Yurasov Mailing Address

Above is the net worth, insider trading, and ownership report for Sergey Yurasov. You might contact Sergey Yurasov via mailing address: C/o Immune Design Corp., 1616 Eastlake Ave. E., Suite 310, Seattle Wa 98102.

Discussions on Sergey Yurasov

No discussions yet.